Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Catheter Directed Therapy for Pulmonary Embolism Proves Successful

By HospiMedica International staff writers
Posted on 24 Nov 2009
A new study claims that-catheter-directed thrombolysis (CDT) should be considered a first-line treatment option for massive blood clots in the lungs.

Researchers at Stanford University Medical Center (CA, USA) conducted a systematic review of electronic literature searches (MEDLINE, EMBASE) for studies published from January 1990 through September 2008. More...
Inclusion criteria were applied to select patients with acute massive pulmonary embolism (PE) treated with modern CDT. Paired reviewers assessed study quality and abstracted data; clinical success was defined as stabilization of hemodynamics, resolution of hypoxia, and survival to hospital discharge.

The researchers found that in 594 patients from 35 studies (6 prospective, 29 retrospective) that met the criteria for inclusion, the pooled clinical success rate from CDT was 86.5%. The pooled risks of minor and major procedural complications were 7.9% and 2.4%, respectively. The researchers also found that not only was the treatment effective, but it also appeared much safer than the historical complication rates reported from injecting high-dose clot-busting medicine systemically or directly into the blood stream, where the drug can circulate throughout the body and cause major bleeding in up to 20% of patients. The study was published in the November 2009 issue of the Journal of Vascular and Interventional Radiology.

"Modern catheter-directed therapy for acute pulmonary embolism saves lives, and we need to raise awareness about its safety and effectiveness not only among the general public but also within the medical community. It's a matter of life and death,” said lead author William Kuo, M.D., of the department of radiology at Stanford. "In our study, we conclude that modern catheter-directed therapy is a relatively safe and effective treatment for acute massive pulmonary embolism and should be considered as a first-line treatment option.”

CTD is performed in a hospital radiology suite by an interventional radiologist, who inserts a catheter into a vein in the leg (generally the popliteal vein) and threads it until it reaches the site of the blood clot. The image-guided catheter allows the doctor to watch the entire procedure on an X-ray video monitor. Once the tip of the catheter reaches the clot, a thrombolytic drug is infused into the clot through the catheter. In most cases, the blood clot will completely dissolve within a few days.

Related Links:

Stanford University Medical Center




Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.